IPO registrations (S-1, F-1) · Registrants
Basel Medical Group Ltd
- SEC CIK
- 2004489 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2024-09-13, last 2026-09-23; 2 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2025-02-25; declared effective 2025-02-18
- Industry (SIC)
- Services-Offices & Clinics of Doctors of Medicine 8011
- Incorporated in
- D8
- Business address
- 600 NORTH BRIDGE ROAD, #12-02/03, PARKVIEW SQUARE, Singapore, U0 188778
- Ticker
- BMGL (Nasdaq)
- EDGAR entity type
- other
- Insiders and CEO pay
- Basel Medical Group Ltd on the corporate pages
Offering terms
- Proposed price range
- $4.00–$5.00 per share (F-1/A filed 2025-02-13)
- Final price
- $4.00 per share, within the range (424B4 filed 2025-02-25, an initial public offering)
- Shares sold
- 2,205,000
- Gross proceeds
- $8,820,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BMGL
- Lead underwriters
- Securities, Inc
- Syndicate
- Cathay Securities; Revere Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Basel Medical Group Ltd EXACT (CIK (EXACT))
Filings 12
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2024-09-13 | F-1 | F-1 (foreign registration) | Basel Medical Group Ltd | 0001493152-24-036168 ↗ |
| 2024-11-04 | F-1/A | F-1/A (amendment) | Basel Medical Group Ltd | 0001493152-24-043455 ↗ |
| 2024-11-14 | F-1/A | F-1/A (amendment) | Basel Medical Group Ltd | 0001493152-24-045646 ↗ |
| 2024-12-03 | F-1/A | F-1/A (amendment) | Basel Medical Group Ltd | 0001493152-24-048457 ↗ |
| 2025-02-13 | F-1/A | F-1/A (amendment) | Basel Medical Group Ltd | 0001493152-25-006287 ↗ |
| 2025-02-18 | EFFECT | EFFECT (declared effective) | Basel Medical Group Ltd | 9999999995-25-000495 ↗ |
| 2025-02-25 | 424B4 | 424B4 (final prospectus) | Basel Medical Group Ltd | 0001493152-25-008234 ↗ |
| 2025-02-25 | 424B4 | 424B4 (final prospectus) | Basel Medical Group Ltd | 0001493152-25-008235 ↗ |
| 2026-09-17 | F-1 | F-1 (foreign registration) | Basel Medical Group Ltd | 0001493152-26-043116 ↗ |
| 2026-09-23 | F-1/A | F-1/A (amendment) | Basel Medical Group Ltd | 0001493152-26-043922 ↗ |
| 2026-09-29 | EFFECT | EFFECT (declared effective) | Basel Medical Group Ltd | 9999999995-26-003102 ↗ |
| 2026-10-08 | 424B4 | 424B4 (final prospectus) | Basel Medical Group Ltd | 0001493152-26-046355 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-13 | F-1/A | registration statement | $4.00–$5.00 | 2,205,000 | - | Nasdaq BMGL | 0 | primary document; range, shares headline | document ↗ | |
| 2025-02-25 | 424B4 | final prospectus | $4.00 | 2,205,000 | $8,820,000 | Nasdaq BMGL | 3 | primary document; price sentence, shares headline, proceeds computed, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| FREUDENTHALER PAUL D | Director | 1 | 2026 | ||
| CHEN TONY | Director | 1 | 2026 | ||
| Chhoa Darren Yen Feng | Officer | Chief Executive Officer | 1 | 2026 | |
| Fung Keng Leong | Director | 1 | 2026 | ||
| Tan Boon Chye | Director,Officer | Chief Commercial Officer | 1 | 2026 | |
| Lu Jianing JN | Officer | Chief Financial Officer | 1 | 2026 | |
| Soong Kwek Yoon | Director | 1 | 2026 | ||
| Neo Alton Chun How | Officer | Interim CFO | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Basel Medical Group Ltd | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Offices & Clinics of Doctors of Medicine, U0 first:
- LYC HEALTHCARE (CAYMAN) LTD U0
- NATIONAL SURGERY CENTERS INC \DE\ IL
- INNOVATIVE CLINICAL SOLUTIONS LTD RI
- METROPOLITAN HEALTH NETWORKS INC FL
- PROMEDCO MANAGEMENT CO TX
- COAST DENTAL SERVICES INC FL
- PHYSICIANS SPECIALTY CORP GA
- U S PHYSICIANS INC PA
- RADIATION THERAPY SERVICES, INC. FL
- PROSPECT MEDICAL HOLDINGS INC CA
In other datasets, the same topic (Health) in U0:
- Form D issuer: EUDA Health Holdings Ltd (Form D private offerings)
Interests: Services-Offices & Clinics of Doctors of Medicine · Health